{
    "title": "Aimmune gets U.S. FDA approval for first peanut allergy drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7954327/Aimmune-gets-U-S-FDA-approval-peanut-allergy-drug.html",
    "date": "2020-01-31",
    "keywords": [
        "drug",
        "treatment",
        "peanut",
        "approval",
        "carl",
        "price",
        "panel",
        "company",
        "palforzia",
        "sensitivity",
        "risk",
        "exposure",
        "response",
        "skin",
        "fda",
        "patch",
        "friday",
        "food",
        "administration",
        "month",
        "list",
        "range",
        "icer",
        "pricing",
        "trading",
        "ar101",
        "brand",
        "name",
        "version",
        "flour",
        "course",
        "httpsreutrs2giuzms",
        "market",
        "relief",
        "allergy",
        "contact",
        "form",
        "reaction",
        "emergency",
        "epipen",
        "epinephrine",
        "goal",
        "point",
        "opportunity",
        "excess",
        "cause",
        "death",
        "constriction",
        "label",
        "warning",
        "aimmune",
        "increase",
        "supervision",
        "allergist",
        "outofpocket",
        "duration",
        "healthcare",
        "therapy",
        "competition",
        "drugmaker",
        "dbv",
        "decision",
        "dbvs",
        "reporting",
        "odonnell",
        "dania",
        "bill",
        "berkrot",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}